Phoenix Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,475
Closed -$87K 152
2021
Q3
$87K Sell
1,475
-50
-3% -$3.29K 0.07% 154
2021
Q2
$102K Hold
1,525
0.07% 154
2021
Q1
$96K Buy
1,525
+87
+6% +$5.41K 0.07% 157
2020
Q4
$89K Buy
+1,438
New +$88.4K 0.07% 153

Other funds holding BMY

Phoenix Wealth Advisors's BMY Position: Q4 2021 in Review

Phoenix Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 1,475 shares — an estimated $87K sold.

Phoenix Wealth Advisors first reported a position in BMY in Q4 2020 and held it in 4 quarters. The position peaked at $102K in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Phoenix Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • Phoenix Wealth Advisors sold 1,475 Bristol-Myers Squibb shares in Q4 2021, an estimated $87K.
  • Phoenix Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 4 quarters.
  • Phoenix Wealth Advisors's Bristol-Myers Squibb position peaked at $102K in Q2 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Phoenix Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.